Literature DB >> 19827894

A descriptive retrospective study of bladder cancer at a hospital in Iran (1973-2003).

Parvin Yavari1, B Sadrolhefazi, M A Mohagheghi, R Mehrazin.   

Abstract

BACKGROUND: Bladder cancer is the ninth most common cancer worldwide, and it is the fourth most common cancer in males in Iran. The objective of this study was to collect, analyze, and discuss epidemiologic features of bladder cancer using data from our University hospital.
METHODS: A review of medical records of 603 patients with histologically confirmed primary malignant bladder tumors who were then referred and treated at the Radiation-Oncology Department during a time period 1973-2003 was performed. The topography and the histology of cases were coded and classified according to the International Classification of Diseases for Oncology (ICD -O) and a frequency distribution of bladder tumors by age at diagnosis, gender, histology types, was calculated. For age and cancer, mean, standard deviation, and 95% confidence intervals were presented. T test and Chi-squared test with p<0.05 were used depending on the variable analyzed, using the SPSS statistical package.
RESULTS: Of the total, 85.2% were males and 15.0% were females (P<0.0001). The mean age of diagnosis was not significantly different between the sexes and the frequency of bladder cancer increased with age in both cases. Overall, two thirds of cases were between 50-74 years of age. For those aged 49 years and below the male to female ratio were 3.6 while after this age the ratio rose to 6.1. The most common histological diagnosis in both sexes among patients was transitional cell carcinoma.
CONCLUSION: The frequency distribution and histologic types of tumors were comparable with reported from other studies.

Entities:  

Mesh:

Year:  2009        PMID: 19827894

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  6 in total

Review 1.  A review of incidence and mortality of colorectal, lung, liver, thyroid, and bladder cancers in Iran and compared to other countries.

Authors:  Bagher Farhood; Behzad Raei; Reza Malekzadeh; Maryam Shirvani; Masoud Najafi; Tohid Mortezazadeh
Journal:  Contemp Oncol (Pozn)       Date:  2019-04-05

2.  Five-Year Survival Rate of Bladder Cancer in Iran during 2001-2007.

Authors:  Maryam Khayamzadeh; Fereshte Aliakbari; Zahra Zolghadr; Majid Emadeddin; Mahsa Ahadi; MohammadEsmaeil Akbari; Amir Reza Abedi; Shahrzad Nematollahi; Jalil Hosseini
Journal:  Iran J Pathol       Date:  2020-10-10

3.  A Retrospective Analysis of Clinical and Pathologic Characteristics of Recurrent Bladder Tumor in a Tertiary Hospital in Addis Ababa, Ethiopia.

Authors:  Andualem Beyene
Journal:  Ethiop J Health Sci       Date:  2021-07

4.  Changing Epidemiology of Common Cancers in Southern Iran, 2007-2010: A Cross Sectional Study.

Authors:  Seyed Masoom Masoompour; Kamran B Lankarani; Behnam Honarvar; Seyed Hamidreza Tabatabaee; Mohsen Moghadami; Zahra Khosravizadegan
Journal:  PLoS One       Date:  2016-05-24       Impact factor: 3.240

5.  Epidemiology and Hospitalization Cost of Bladder Cancer in Kerman Province, Southeastern Iran.

Authors:  Hamideh Rashidian; Kazem Zendehdel; Rajabali Daroudi; Mohammad Reza Ebadzadeh; Ali Akbar Haghdoost
Journal:  Iran J Public Health       Date:  2018-04       Impact factor: 1.429

Review 6.  Bladder Cancer in Iran: An Epidemiological Review.

Authors:  Khadijeh Kalan Farmanfarma; Neda Mahdavifar; Hamid Salehiniya
Journal:  Res Rep Urol       Date:  2020-03-05
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.